Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02256527 · ClinicalTrials.gov registry record
REWARDS Premier Taxus-Liberte vs Xience V
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 917
- Enrollment target
NCT02256527 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 917 participants.
The verdict
NCT02256527 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 917 participants
- Enrollment target
Study Summary
Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in which patients received either the Taxus Liberte or XIENCE V drug eluting stent.
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 917 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02256527
The ClinicalTrials.gov registry entry for NCT02256527 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 917 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT02256527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02256527 about?
NCT02256527 is a clinical study titled "REWARDS Premier Taxus-Liberte vs Xience V". Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in which patients received ...
What is the current status of trial NCT02256527?
This trial is currently completed. The enrollment target is 917 participants. The study started on 2014-09. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02256527?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT02256527?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.